Aptevo Therapeutics Inc. (APVO) (CIK 0001671584) (APVO)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Aug. 31, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 31, 2026 | CORRESP | Neutral/Informational | High | Aptevo Therapeutics Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1, originally filed on August 21, … | Read Filing EDGAR |
| Aug. 27, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated August 27, 2026, informs Jeffrey G. Lamothe, CEO of Aptevo Therapeutics Inc., that the SEC has not reviewed and will not review their registration sta… | Read Filing EDGAR |
| Jan. 29, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has notified Aptevo Therapeutics Inc. that it will not review their registration statement filed on January 28, 2026. The letter emphasizes the company's responsibility fo… | Read Filing EDGAR |
| Jan. 29, 2026 | CORRESP | Neutral/Informational | High | Aptevo Therapeutics Inc. has submitted a request to the SEC for the acceleration of the effective date of its Registration Statement on Form S-1, which was filed on January 28, 20… | Read Filing EDGAR |
| Nov. 24, 2025 | CORRESP | Neutral/Informational | Moderate | Aptevo Therapeutics Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1, which was filed on October 1, 2… | Read Filing EDGAR |